Ftse Mib
33.414,56
0,46%
DAX
19.626,45
1,05%
S&P 500
6.032,38
0,56%
NASDAQ
19.218,17
0,83%
Bitcoin
96.772,89
-0,73%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ OKYO Pharma Ltd (OKYO) OKYO Pharma Ltd (OKYO) Notizie

OKYO Pharma Ltd

OKYO
1,03
-0,01 (-0,96%)
29 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/11/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202413:00GLOBEOKYO Pharma to Participate at the 4th Annual BTIG..
30/10/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202412:00GLOBEOKYO Pharma to Present at International Tear Film and Ocular..
23/10/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202413:00GLOBEOKYO Pharma Announces First Patient Dosed in the First..
16/10/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202413:00GLOBEOKYO Pharma Announces Start of Phase 2 Clinical Trial to..
10/9/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/9/202413:00GLOBEOKYO Pharma Announces Chairman Acquires Shares
05/9/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202413:00GLOBEOKYO Pharma Announces Chairman Acquires Shares
27/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/8/202413:00GLOBEOKYO Pharma Granted U.S. Patent Covering OK-101’s Potential..
23/8/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202415:00GLOBEOKYO Pharma CEO Interview to Air on Bloomberg TV
23/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202413:00GLOBEOKYO Pharma Announces Chairman Acquires Shares
21/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/8/202413:00GLOBEOKYO Pharma Announces Chairman Acquires Shares
15/8/202419:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202418:13GLOBEOKYO Pharma Participates in H.C. Wainwright 4th Annual..
13/8/202422:30EDGAR2Form 20-F - Annual and transition report of foreign private..
06/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/8/202413:00GLOBEOKYO Pharma Granted European Patent Covering OK-101 Chemerin..
31/7/202423:00EDGAR2Form NT 20-F - Notification of inability to timely file Form..
11/7/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202413:00GLOBEOKYO Pharma to Initiate Neuropathic Corneal Pain Trial for..
10/7/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202413:00GLOBEOKYO Pharma Announces Promising Categorical Data from OK-101..
10/7/202412:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/5/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/5/202413:00GLOBEOKYO Pharma Announces Participation in May 2024 Investor..
30/4/202413:00GLOBEOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
09/4/202401:00GLOBEOKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
02/4/202413:00GLOBEOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
22/3/202412:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
21/3/202412:00GLOBEOKYO Pharma to Host Key Opinion Leader Event to Discuss New..
20/3/202412:00GLOBEOKYO Pharma to Release New and Comprehensive Data from Phase..
09/2/202413:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
09/2/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/2/202413:00GLOBEOKYO Pharma Receives FDA Approval of IND for OK-101 in..
31/1/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202413:00GLOBEOKYO Pharma Announces Distinguished Ophthalmologists with..
08/1/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202413:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
05/1/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202415:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
21/12/202313:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202323:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 1,04 Min: 1,0214 Max: 1,06
Chiusura: 1,04

La tua Cronologia

NASDAQ
OKYO
OKYO Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network